Nutrition and Cancer

por Wilkinson, P. M.
Publicado 1979

Antibiotics and Chemotherapy. 24. Application of Cancer Chemotherapy

por Wilkinson, P. M.
Publicado 1979

Opportunistic Infection in Cancer Patients

por Wilkinson, P. M.
Publicado 1979

High Dose Methotrexate Pharmacology, Toxicology and Chemotherapy. Proceedings of an International Workshop, Firenze 1978

por Wilkinson, P. M.
Publicado 1980

New approaches in cancer therapy II

por Wilkinson, P.M.
Publicado 1983

Pharmacologic Principles of Cancer Treatment

por Wilkinson, P. M.
Publicado 1983

Pharmacologic Principles of Cancer Treatment

por Wilkinson, P.M.
Publicado 1983

Clinical Cancer Chemotherapy

por Wilkinson, P. M.
Publicado 1976

Cancer Therapy: Prognostic Factors and Criteria of Response

por Wilkinson, P. M.
Publicado 1976

The treatment of advanced seminoma with chemotherapy and radiotherapy.

por Wilkinson, P. M., Read, G., Magee, B.
Publicado 1988

The role of radiotherapy after chemotherapy in the management of persistent para-aortic nodal disease in non-seminomatous germ cell tumours.

por Read, G., Johnson, R. J., Wilkinson, P. M.
Publicado 1986

Cyclophosphamide and Nandrolone Decanoate in the Treatment of Advanced Carcinoma of the Breast—Results of a Comparative Controlled Trial of the Agents Used Singly and in Combinatio...

por Cole, M. P., Todd, I. D. H., Wilkinson, P. M.
Publicado 1973

A Preliminary Trial of Doxorubicin in Advanced Breast Cancer and Other Malignant Disease

por Cole, M. P., Todd, I. D. H., Wilkinson, P. M.
Publicado 1974

Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker.

por Canney, P. A., Moore, M., Wilkinson, P. M., James, R. D.
Publicado 1984

CA19-9 as a marker for ovarian cancer: alone and in comparison with CA125.

por Canney, P. A., Wilkinson, P. M., James, R. D., Moore, M.
Publicado 1985

Epoetin alfa in platinum-treated ovarian cancer patients: results of a multinational, multicentre, randomised trial

por Wilkinson, P M, Antonopoulos, M, Lahousen, M, Lind, M, Kosmidis, P
Publicado 2006

Lack of effect of immunotherapy with BCG and Corynebacterium parvum on hepatic drug hydroxylation in man.

por Wan, H. H., Thatcher, N., Mullen, P. W., Smith, G. N., Wilkinson, P. M.
Publicado 1979

Granulocyte function in myeloblastic leukaemia.

por Wilkinson, P. M., Sumner, C., Delamore, I. W., Geary, C. G., Milner, G. R.
Publicado 1975

A new immunoassay using monoclonal antibodies HMFG1 and HMFG2 together with an existing marker CA125 for the serological detection and management of epithelial ovarian cancer.

por Dhokia, B., Canney, P. A., Pectasides, D., Munro, A. J., Moore, M., Wilkinson, P. M., Self, C., Epenetos, A. A.
Publicado 1986

SCOTROC 2B: feasibility of carboplatin followed by docetaxel or docetaxel–irinotecan as first-line therapy for ovarian cancer

por Clamp, A R, Mäenpää, J, Cruickshank, D, Ledermann, J, Wilkinson, P M, Welch, R, Chan, S, Vasey, P, Sorbe, B, Hindley, A, Jayson, G C
Publicado 2006